Nao-xin-tong capsule attenuates cerebral ischemia/reperfusion injury by modulating the p53/GDF15/NOX4 regulatory network and alleviating mitochondrial dysfunction and ferroptosis-related injury
- 18 June 2026
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 371, 122060
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 80 references indexed in Scilit:
- E2F1/CDK5/DRP1 axis mediates microglial mitochondrial division and autophagy in the pathogenesis of cerebral ischemia‐reperfusion injuryClinical and Translational Medicine, 2025
- Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled TrialChinese Journal of Integrative Medicine, 2022
- Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic StrokeNeuroscience Bulletin, 2022
- Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine HospitalChinese Journal of Integrative Medicine, 2022
- Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohortEuropean Journal of Epidemiology, 2021
- ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammationBrain, Behavior, and Immunity, 2021
- Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in strokeIUBMB Life, 2021
- p53 and mitochondrial dysfunction: novel insight of neurodegenerative diseasesJournal of Bioenergetics and Biomembranes, 2016
- Mitochondrial ATP synthase: architecture, function and pathologyJournal of Inherited Metabolic Disease, 2011
- Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemiaCell and tissue research, 2010